患有高风险左心室缩的患者心肌硬度增加:B期心力衰竭的标志
在PubMed上查看摘要
概括
此摘要是机器生成的。中年患者左心室缩 (LVH) 和心脏生物标志物升高显示左心室肌肉硬度增加. 这一发现表明心力衰竭的过渡状态与保存的喷射分数 (HFpEF).
科学领域
- 心脏病学
- 心血管生理学
- 生物医学工程
背景情况
- 患有左心室缩 (LVH) 和心脏生物标志物升高的中年人面临心力衰竭 (HFpEF) 的高风险.
- 这种高风险的潜在病理生理机制尚不清楚.
- 本研究调查左心室肌肉硬度增加是否导致这种高风险状态.
研究的目的
- 测试 LVH 和心脏生物标志物升高的患者与健康对照人群相比,心肌硬度增加的假设.
- 确定心肌硬作为未来HFpEF发展的潜在标志物.
主要方法
- 招募了46名患有 LVH 和心脏生物标志物升高的患者,以及61名健康对照患者.
- 使用右心导管和3D心声学来评估LV压力-体积关系.
- 使用下体负压和盐水输液进行操作预充.
主要成果
- 与对照组相比,LVH患者的LV阻抗能力显著降低.
- 在LVH组,心肌硬度比对照组高近30% (硬度常数:0. 053±0. 027).
- 在两组之间观察到体型,血压和肺毛细血管压的显著差异.
结论
- 患有LVH和生物标志物的LV心肌硬度升高表明HFpEF的过渡阶段.
- 这种增加的硬度可能是HFpEF的早期标志物.
- 需要进一步的研究来探索干预措施,比如运动训练,以改善LV遵守并可能防止HFpEF的表现.
相关概念视频
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

